Literature DB >> 25035274

Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.

Richard J Glassock1.   

Abstract

Entities:  

Keywords:  anti-PLA2R antibodies; glomerulonephritis; membranous GN

Mesh：

Substances：

Year:  2014        PMID： 25035274      PMCID： PMC4123392          DOI： 10.2215/CJN.05880614

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  17 in total

1.  Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis.

Authors:  Iva Gunnarsson; Wolfgang Schlumberger; Johan Rönnelid
Journal:  Am J Kidney Dis       Date:  2011-12-16       Impact factor: 8.860

2.  Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.

Authors:  Corrado Murtas; Maurizio Bruschi; Giovanni Candiano; Gabriella Moroni; Riccardo Magistroni; Andrea Magnano; Francesca Bruno; Antonella Radice; Luciana Furci; Lucia Argentiero; Maria Luisa Carnevali; Piergiorgio Messa; Francesco Scolari; Renato Alberto Sinico; Loreto Gesualdo; Fernando C Fervenza; Landino Allegri; Pietro Ravani; Gian Marco Ghiggeri
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

3.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

4.  A case of phospholipase A₂ receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis.

Authors:  Masa Knehtl; Hanna Debiec; Prochore Kamgang; Patrice Callard; Jacques Cadranel; Pierre Ronco; Jean-Jacques Boffa
Journal:  Am J Kidney Dis       Date:  2010-11-17       Impact factor: 8.860

5.  Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy.

Authors:  Zhen Qu; Gang Liu; Jun Li; Li-hua Wu; Ying Tan; Xin Zheng; Jie Ao; Ming-hui Zhao
Journal:  Nephrol Dial Transplant       Date:  2011-10-05       Impact factor: 5.992

6.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

7.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Authors:  Laurence H Beck; Fernando C Fervenza; David M Beck; Ramon G B Bonegio; Fahim A Malik; Stephen B Erickson; Fernando G Cosio; Daniel C Cattran; David J Salant
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

8.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Laurence H Beck; David M Beck; Jack F Wetzels; David J Salant
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-07       Impact factor: 8.237

9.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

10.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

Authors:  Anneke P Bech; Julia M Hofstra; Paul E Brenchley; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237
View more
  9 in total

1.  American Society of Nephrology quiz and questionnaire 2014: glomerular diseases.

Authors:  Andrew S Bomback; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-09       Impact factor: 8.237

Review 2.  Changing the concepts of immune-mediated glomerular diseases through proteomics.

Authors:  Dawn J Caster; Liliane Hobeika; Jon B Klein; David W Powell; Kenneth R McLeish
Journal:  Proteomics Clin Appl       Date:  2015-06-17       Impact factor: 3.494

Review 3.  A Proposal for a Serology-Based Approach to Membranous Nephropathy.

Authors:  An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 10.121

Review 4.  The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.

Authors:  Iwona Smarz-Widelska; Dariusz Chojęta; Małgorzata M Kozioł
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

5.  Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.

Authors:  Francesco Scolari; Elisa Delbarba; Domenico Santoro; Loreto Gesualdo; Antonello Pani; Nadia Dallera; Laila-Yasmin Mani; Marisa Santostefano; Sandro Feriozzi; Marco Quaglia; Giuliano Boscutti; Angelo Ferrantelli; Carmelita Marcantoni; Patrizia Passerini; Riccardo Magistroni; Federico Alberici; Gian Marco Ghiggeri; Claudio Ponticelli; Pietro Ravani
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

6.  A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.

Authors:  Qiuhua Zhang; Xiaobin Liu; Zhijian Zhang; Mian Wu; Biao Huang; Yi Zhang; Bin Liu; Zhen Qi; Weiwei Shan; Liang Wang; Zhigang Hu; Zhuxing Sun
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

Review 8.  Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.

Authors:  Bogdan Obrisca; Gener Ismail; Roxana Jurubita; Catalin Baston; Andreea Andronesi; Gabriel Mircescu
Journal:  Biomed Res Int       Date:  2015-10-20       Impact factor: 3.411

9.  Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer.

Authors:  Le Deng; Qipeng Huang; Jiang Wang; Kaiping Luo; Jiarong Liu; Wenjun Yan; Fang Jiang; Gaosi Xu
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.